GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Family Office of America Inc (OTCPK:FOFA) » Definitions » 5-Year Dividend Growth Rate

FOFA (Family Office of America) 5-Year Dividend Growth Rate : 0.00% (As of Sep. 2024)


View and export this data going back to 2006. Start your Free Trial

What is Family Office of America 5-Year Dividend Growth Rate?

Family Office of America's Dividends per Share for the three months ended in Sep. 2024 was $0.00.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

Family Office of America's Dividend Payout Ratio for the three months ended in Sep. 2024 was 0.00. As of today, Family Office of America's Dividend Yield % is 0.00%.

For more information regarding to dividend, please check our Dividend Page.


Competitive Comparison of Family Office of America's 5-Year Dividend Growth Rate

For the Medical Devices subindustry, Family Office of America's 5-Year Dividend Growth Rate, along with its competitors' market caps and 5-Year Dividend Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Family Office of America's 5-Year Dividend Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Family Office of America's 5-Year Dividend Growth Rate distribution charts can be found below:

* The bar in red indicates where Family Office of America's 5-Year Dividend Growth Rate falls into.



Family Office of America 5-Year Dividend Growth Rate Calculation

This is the average annual rate that a company has been raising its dividends. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.


Family Office of America  (OTCPK:FOFA) 5-Year Dividend Growth Rate Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Family Office of America's Dividend Payout Ratio for the quarter that ended in Sep. 2024 is calculated as

Dividend Payout Ratio=Dividends per Share (Q: Sep. 2024 )/ EPS without NRI (Q: Sep. 2024 )
=0/ -0.001
=N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Family Office of America 5-Year Dividend Growth Rate Related Terms

Thank you for viewing the detailed overview of Family Office of America's 5-Year Dividend Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Family Office of America Business Description

Traded in Other Exchanges
N/A
Address
6898 S. University Boulevard, Suite 100, Centennial, CO, USA, 80122
Qualis Innovations Inc. is the holding company of mPathix Health, Inc. The company is focused on the development, production, and distribution of multi-modal pain management and Central Nervous System related solutions. It develops pain management products using a modality-agnostic, virtual operating model. The company is developing a product designed to address the unmet needs of patients who seek alternatives to traditional pain medications and interventions or adjunctive therapies to their current treatment regimen.
Executives
Bin Wang director 112 RICO DR. NORTH, MORGANVILLE NJ 07751